Evidence suggests elevated SLFN12 methylation levels in CD4+ and CD8+ T cells in the peripheral blood of patients with multiple sclerosis, a chronic inflammatory disease of the central nervous system. The gene discussed is CD8A; the disease is multiple sclerosis.